Sharing data from MS clinical trials: Opportunities, challenges, and future directions. (October 2015)

• Record Type: Journal Article
• Authors: Coetzee, Timothy
• Is Part Of: Multiple sclerosis. Volume 21:Number 11(2015)
• Page Start: 1365
• Page End: 1368
• Publication Date: 2015-10
• Subjects: Clinical trial -- multiple sclerosis -- data sharing -- information sharing -- patient advocacy; Central nervous system -- Diseases -- Periodicals; Myelin sheath -- Diseases -- Periodicals; Inflammation -- Periodicals; Multiple sclerosis -- Periodicals; Central Nervous System Diseases -- Periodicals; Demyelinating Diseases -- Periodicals; Inflammation -- Periodicals; Multiple Sclerosis -- Periodicals; Système nerveux central -- Maladies -- Périodiques; Gaine de myéline -- Maladies -- Périodiques; Inflammation (Pathologie) -- Périodiques; Sclérose en plaques -- Périodiques; Electronic journals; 616.834005
• DOI: 10.1177/1352458515608005
• Languages: English
• ISSNs: 1352-4585

Abstract

The treatment of people affected by multiple sclerosis, particularly the relapsing forms of the disease, has been transformed by the availability of various therapeutic agents. This landmark progress is due to an enormous foundation of clinical research and, particularly, numerous phase II and III clinical trials. Although the research community has many reasons to take pride in this progress, a fundamental question remains about whether opportunities for additional research are being lost due to inadequate clinical trial data sharing.